Never miss a great news story!
Get instant notifications from Economic Times
AllowNot now


You can switch off notifications anytime using browser settings.
11,856.80-80.7
Stock Analysis, IPO, Mutual Funds, Bonds & More
USV in talks with Novartis to buy Jalra Trademark for Rs. 200 Crore

Mumbai-based drugmaker USV Pvt Ltd is in advanced discussions to acquire the trademark for antidiabetes drug Jalra from Novartis for a deal valued at more than Rs. 200 crore.

Dr Reddy's Labs launches generic injection indicated for abortion in US

The company has launched Carboprost Tromethamine injection USP, 250 mcg/mL (1mL) single-dose vial in the US market, the pharma major said in a filing to BSE.

Mankind Pharma launches drug for treatment of infertility in India

With the launch, the company has become the first Indian and second global firm to develop the drug, Mankind Pharma said in a statement. The company's product is generic version of Abbott's Duphaston tablets, it added. The manufacturing process of Dydrogesterone is very complex as it involves conversion of natural progesterone, the statement said.

Zydus Cadila files NDA for Saroglitazar Magnesium

NASH is a progressive disease of the liver and a significant unmet medical need. There are currently no treatments available for the treatment of NASH. aroglitazar Mg has previously demonstrated improvement in both liver enzymes along with favorable effects on lipid and glycemic indices in patients with nonalcoholic fatty liver disease in Phase II clinical trials.

Biocon sees a sweet spot with its affordable insulin in US

The biotech firm is also planning to provide its rh-insulin to middle- and low-income countries at less than 10 cents a day. Biocon Biologics is chasing a revenue target of $1 billion in financial year 2021-22. In the previous fiscal year, its revenue had topped $200 million.

Central drugs regulator asks states, UTs to stop online sale of medicines

DCGI has asked all drug regulators in states and Union Territories to prohibit sale of drugs by online pharmacies.

Strides Pharma gets tentative nod from USFDA for pain relieving drug

Strides Pharma Global Pte Ltd, Singapore, has received tentative approval for Diclofenac Potassium Softgel Capsules, 25 mg from the United States Food & Drug Administration (USFDA), Strides Pharma Science said in a regulatory filing.

States told to restrain unlicenced e-pharmacies

The Drug Controller General of India (DCGI) has asked the state-level drug regulators to ensure that e-pharmacies don’t sell medicines without a licence.

Founders seeking exit value Sequent Scientific at Rs 2,500 crore

Sequent’s market cap as on Tuesday was Rs 1,670 crore. But the founders are seeking a control premium of 49.7% or 18-20x forward Ebitda multiple, valuing the company at Rs 2,100-2,500 crore, sources said. Some, however, worry that such expectations may turn out to be a potential deal breaker.

E-pharmacies await govt to release regulations for the sector

"We want India to come up with a progressive e-pharmacy regulation. We want that as that would give a lot of clarity and confidence to the sector, whether it is investors, whether it is our business partners and vendors," 1mg Technologies Founder and CEO Prashant Tandon told reporters here. The government is yet to release the final notification.

Biocon, Mylan launch cancer drug in US market

Biocon, Mylan launch cancer drug in US market

Ogivri, available in a 420mg multi-dose vial and a 150mg single-dose vial, will be used for treatment of all types of breast cancer and metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma).

Sun Pharma gets partial relief from US court in litigation involving three generic drugs

Sun Pharma gets partial relief from US court in litigation involving three generic drugs

Drug major Sun Pharma is a defendant in a multi-district litigation brought by various classes of plaintiffs in the US District Court (District of Massachusetts), alleging a delay in the market entry for three generic drugs -- Valganciclovir, Valsartan and Esomeprazole. The company said it would continue to vigorously defend against all claims.

Volume with low cost is Biocon Biologics’ big plan

Volume with low cost is Biocon Biologics’ big plan

The Biocon subsidiary will chart a path that ensures high volumes and low costs, unlike competitors. The company plans to create an ecosystem where patients not only have access to the right medicine, but also gets the right care without always reaching a hospital.

Roche India head Lara Bezerra set to exit

Roche India head Lara Bezerra set to exit

A Roche India spokesperson confirmed the development and said an announcement for a new India head will be made soon. “Dec. 1 will be the date for Lara to end the assignment. During her tenure at Roche India, Lara successfully led the organization with passion and commitment and shaped the culture of the organization,”the statement added.

Pharma Inc agrees to cap margins on non-price control drugs at 30%

Pharma Inc agrees to cap margins on non-price control drugs at 30%

Big pharma companies with generic divisions — such as Sun Pharma, Cipla and Lupin — will have to reduce MRP.

Need Malvinder Singh's custody to confront him with docs, witnesses in RFL scam, ED tells HC

Need Malvinder Singh's custody to confront him with docs, witnesses in RFL scam, ED tells HC

The trial court had on November 23 dismissed the agency's application for further custodial interrogation of Singh and Godhwani and had sent them to judicial custody till December 7.

Load More...
1

Other useful Links


Follow us on


Download et app


Copyright © 2019 Bennett, Coleman & Co. Ltd. All rights reserved. For reprint rights: Times Syndication Service

BACK TO TOP